Results 21 to 30 of about 149,520 (398)

Comprehensive data analysis of human ureter proteome

open access: yesData in Brief, 2016
Comprehensive human ureter proteome dataset was generated from OFFGel fractionated ureter samples. Our result showed that among 2217 non-redundant ureter proteins, 751 protein candidates (33.8%) were detected in urine as urinary protein/polypeptide or ...
Sameh Magdeldin   +8 more
doaj   +1 more source

Localized Amyloid A amyloidosis of ureter: A case report

open access: yesUrology Case Reports, 2023
Amyloidosis of the ureter is a rare disease, distinguishing it from a neoplasm is difficult. A 64-year-old Japanese woman suffered from macrohematuria and left side hydronephrosis with ultrasound in 2014.
Kaori Yamashita   +6 more
doaj   +1 more source

Retrocaval ureter presenting at 6 years of age in a girl child – An extreme rarity

open access: yesAsian Journal of Urology, 2016
Retrocaval ureter is one of the very rare congenital anomalies. We report a case of retrocaval ureter in a 6-year-old girl who presented with right flank pain and hydronephrosis.
Pradeep Kajal   +3 more
doaj   +1 more source

Rare case of carcinoma in situ originated in right retrocaval ureter successfully managed with laparoscopic procedure

open access: yesIJU Case Reports, 2020
Introduction A retrocaval ureter is a rare congenital abnormality characterized by the persistence of the posterior subcardinal vein on the right, which causes the proximal ureter to deviate medially behind the inferior vena cava.
Yusuke Noda   +9 more
doaj   +1 more source

Left retrocaval ureter without situs inversus or inferior venacava duplication

open access: yesIndian Journal of Urology, 2015
Retrocaval ureter (pre-ureteral vena cava) is an uncommon congenital anomaly that causes ureteral obstruction by external compression. Although right retrocaval ureter is a common entity, left retrocaval ureter is extremely rare. A left retrocaval ureter
Vasudevan Thirugnanasambandam   +2 more
doaj   +1 more source

Free ureteral replacement in rats: regeneration of ureteral wall components in the acellular matrix graft. [PDF]

open access: yes, 1997
ObjectivesTo evaluate ureteral replacement by a free homologous graft of acellular matrix in a rat model.MethodsIn 30 male Sprague-Dawley rats, a 0.3 to 0.8-cm midsegment of the left ureter was resected and replaced with an acellular matrix graft of ...
Dahiya, R   +5 more
core   +1 more source

STONE FREE RATES OF KIDNEY STONE WAS LOWER THAN THE ONE OF URETER STONE PATIENTS MANAGED BY ESWL AND THE ONE OF URETER STONE MANAGED BY URETEROLITHOTRIPSY

open access: yesJurnal Urologi Indonesia, 2018
Objective: To evaluate the stone free rates of kidney and ureter stone patients managed by Extracorporeal Shockwave Lithotripsy (ESWL), and the ureter stone free rate managed by ureterolithotripsy.
Zuhirman Zamzami
doaj   +1 more source

Surgical management for upper tract transitional cell carcinoma [PDF]

open access: yes, 2008
This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2008, Issue 4. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic
Cohen, Nicholas P.   +5 more
core   +3 more sources

Endoscopic laser-ablation for the treatment of orthotopic and ectopic ureteroceles in dogs: 13 cases (2008-2017). [PDF]

open access: yes, 2019
BACKGROUND: Ureteroceles are a rare condition in dogs in which conventional treatments can result in substantial morbidity. Cystoscopic and fluoroscopic-guided laser ablation (CLA) of ureteroceles can successfully relieve obstruction.
Ather MH   +9 more
core   +2 more sources

Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin) : study protocol for a randomized controlled trial [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Anson, Ken   +12 more
core   +2 more sources

Home - About - Disclaimer - Privacy